2007 Cannabinoids Data Treatment 
Cannabis Law Report
JANUARY 23, 2022
At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments. More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-de?ciency Many variables impact the outcomes of GVHD. Implications.
Cannabis Chronicles
JANUARY 30, 2019
— writer Malcolm Gladwell focused on a 2017 report by the National Academy of Medicine that examined the scientific evidence of the health effects and therapeutic purposes of cannabis and cannabinoids. Not everyone in the field of cannabis and cannabinoid research was put off by the articles. In 2017, for example, Washington had 304.5
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
OCTOBER 29, 2019
The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.
Greencamp
FEBRUARY 2, 2019
Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. What is HIV and how is it manifested? Human immunodeficiency virus (HIV), as the name implies, harms the immune system. Cannabis as medicine against HIV.
Cannabis Law Report
JULY 8, 2021
Despite the fact that cannabis also isn’t approved for use by the Food & Drug Administration, advocacy organizations claim that smoking cannabis is a viable treatment for a number of behavioral and health issues, ranging from tension and worry to Frontotemporal disease and Parkinson’s disease (FDA). million) and 2007.
CannaMD
JULY 8, 2020
The authors note that marijuana cannabinoids, THC and CBD , appear to have antidepressant-like effects in animal models, and report that in human surveys: Medical cannabis users perceived a 50% reduction in depression and a 58% reduction in anxiety and stress following cannabis use. Final Thoughts.
Greencamp
APRIL 23, 2019
For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. Since so little is known about the exact cause of this condition, and a cure hasn’t been found yet, treatment options are limited but they do exist. What is multiple sclerosis? Scientific research on cannabis and MS.
Expert insights. Personalized for you.
52 
Let's personalize your content